首页 | 本学科首页   官方微博 | 高级检索  
     


TRANSFORM (Multicenter Experience With Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement) US clinical trial: Performance of a rapid deployment aortic valve
Authors:Glenn R. Barnhart  Kevin D. Accola  Eugene A. Grossi  Y. Joseph Woo  Mubashir A. Mumtaz  Joseph F. Sabik  Frank N. Slachman  Himanshu J. Patel  Michael A. Borger  H. Edward Garrett  Evelio Rodriguez  Patrick M. McCarthy  William H. Ryan  Francis G. Duhay  Michael J. Mack  W. Randolph Chitwood
Affiliation:1. Swedish Heart and Vascular Institute, Structural Heart Program, Seattle, Wash;2. Florida Hospital Cardiovascular Institute, Florida Hospital Orlando, Orlando, Fla;3. Department of Cardiothoracic Surgery, New York University School of Medicine, New York, NY;4. Department of Cardiothoracic Surgery, Stanford University, Palo Alto, Calif;5. Cardiovascular & Thoracic Surgery, Pinnacle Health, Harrisburg, Pa;6. Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Cleveland, Ohio;7. Mercy Medical Group, Mercy General Hospital, Sacramento, Calif;8. Cardiac Surgery Department, University of Michigan, Ann Arbor, Mich;9. Department of Surgery, Columbia University Medical Center, New York, NY;10. Cardiovascular Surgery Clinic, Baptist Memorial Hospital, Memphis, Tenn;11. Saint Thomas Heart Program, Saint Thomas Heart Hospital, Nashville, Tenn;12. Division of Cardiac Surgery, Northwestern Memorial Hospital, Chicago, Ill;13. Cardiac Surgery Specialists, Baylor Plano Heart Hospital, Plano, Tex;14. Edwards Lifesciences LLC, Irvine, Calif;15. Department of Cardiovascular Sciences, East Carolina University, Greenville, NC
Abstract:

Background

The TRANSFORM (Multicenter Experience With Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement) trial (NCT01700439) evaluated the performance of the INTUITY rapid deployment aortic valve replacement (RDAVR) system in patients with severe aortic stenosis.

Methods

TRANSFORM was a prospective, nonrandomized, multicenter (n = 29), single-arm trial. INTUITY is comprised of a cloth-covered balloon-expandable frame attached to a Carpentier-Edwards PERIMOUNT Magna Ease aortic valve. Primary and effectiveness endpoints were evaluated at 1 year.

Results

Between 2012 and 2015, 839 patients underwent RDAVR. Mean age was 73.5 ± 8.3 years. Full sternotomy (FS) was used in 59% and minimally invasive surgical incisions in 41%. Technical success rate was 95%. For isolated RDAVR, mean crossclamp and cardiopulmonary bypass times for FS were 49.3 ± 26.9 minutes and 69.2 ± 34.7 minutes, respectively, and for minimally invasive surgical 63.1 ± 25.4 minutes and 84.6 ± 33.5 minutes, respectively. These times were favorable compared with Society of Thoracic Surgeons database comparators for FS: 76.3 minutes and 104.2 minutes, respectively, and for minimally invasive surgical, 82.9 minutes and 111.4 minutes, respectively (P < .001). At 30 days, all-cause mortality was 0.8%; valve explant, 0.1%; thromboembolism, 3.5%; and major bleeding, 1.3%. In patients with isolated aortic valve replacement, the rate of permanent pacemaker implantation was 11.9%. At 1 year, mean effective orifice area was 1.7 cm2; mean gradient, 10.3 mm Hg; and moderate and severe paravalvular leak, 1.2% and 0.4%, respectively.

Conclusions

INTUITY RDAVR performed effectively in this North American trial. It may lead to a relative reduction in aortic crossclamp time and cardiopulmonary bypass time and has excellent hemodynamic performance. Pacemaker implantation rate observed was somewhat greater than European trials and requires further investigation.
Keywords:aortic valve replacement  rapid deployment valves  sutureless valves  calcific aortic stenosis  minimally invasive surgery  AT  as-treated  AVR  aortic valve replacement  CPBT  cardiopulmonary bypass time  EOA  effective orifice area  LPY  late patient-years  LVOT  left ventricular outflow tract  NYHA  New York Heart Association  OPC  objective performance criteria  PVL  paravalvular leak  RDAVR  rapid deployment aortic valve replacement  STS  Society of Thoracic Surgeons  SVD  structural valve deterioration  TRANSFORM  XCT  crossclamp time
本文献已被 ScienceDirect 等数据库收录!
正在获取相似文献,请稍候...
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号